Small hybrid heteroaromatics: resourceful biological tools in cancer research

Abstract

Nowadays, hybrid drugs containing two or more covalently linked known potential pharmacophores are designed to simultaneously modulate multiple targets of multifactorial diseases to overcome the side effects associated with a single drug.